PICK A TIME SLOT
₹ Price not available
Ranchi
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Satish Sharma is a Consultant in the Department of Medical Oncology at Bhagwan Mahavir Manipal Hospitals, Ranchi, with over eight years of focused clinical and academic experience in managing complex cancer cases through Chemotherapy, Targeted Therapy, Immunotherapy, and Multidisciplinary Treatment approaches. After completing his MBBS in 2014, DNB in Medicine in 2018, and DM in Medical Oncology in 2022, Dr. Sharma has built a strong foundation in evidence-based cancer care. He has qualified for the Zonal Round of TYSA in Medical Oncology and cleared the ECMO examination, reinforcing his academic proficiency.
His active participation in global oncology forums, including the American Society of Clinical Oncology (ASCO), highlights his engagement with the latest developments in oncology. Dr. Sharma’s research includes peer-reviewed contributions such as “Impact of Nationwide Lockdown on Cancer Care during COVID-19: A Retrospective Analysis from Western India” (ASCO 2022) and “Tumour-Induced Osteomalacia” (ASEAN Endocrine Journal, 2016). His additional publications, including “Mesenteric Leiomyosarcoma: Long-Term Survival Possible” and “Interstitial Lung Disease in Rheumatoid Arthritis: A Prospective Study at a Tertiary Care Centre” (Indian Journal of Chest Disease & Allied Sciences, 2022), demonstrate his multidisciplinary focus and research depth.
- Hindi
- English
- Zonal Round TYSA, Medical Oncology. Qualified ECMO exam.
- Took part in many national and international conferences (including ASCO).
- Guest Speaker at Jasicon 2022 at Hazaribagh.
- Expert Speaker at Ramgarh IMA CME. Speaker at Deoghar CME on Advances in Colon Cancer.
- Nursing awareness programme at Sarla Birla University (SBU).
- Health awareness program at Kairali School, Ranchi.
- Lung cancer awareness among the masses at Radio Big FM and Radio City.
- Spoke about “Advances in Lung and Breast Cancer” at CME, Daltonganj.
- Impact of Nationwide Lockdown on Cancer Care During COVID-19 Pandemic: "A Retrospective Analysis from Western India" – ASCO, 2022.
- "Tumour Induced Osteomalacia" – published in ASEAN Endocrine Journal, 2016.
- Myocardial Sarcoidosis – "Complete Remission on PET” – sent to NEJM, 2017.
- Mesenteric Leiomyosarcoma – "Long-Term Survival Possible” – sent to Frontiers.
- Interstitial Lung Disease in Rheumatoid Arthritis: "A Prospective Study at a Tertiary Care Centre" – published in The Indian Journal of Chest Diseases & Allied Sciences, 2022.
- Successful Rechallenge of Bevacizumab After Grade 4 Bevacizumab-Induced Hypertension in a Case of Carcinoma Ovary – "Is Rechallenging an Option? A Rare Case Report" – published in GSC Biologicals.
Overview
Languages Spoken
Awards & Achievements
Talks & Publications
- Hindi
- English
Dr. Satish Sharma is a Consultant in the Department of Medical Oncology at Bhagwan Mahavir Manipal Hospitals, Ranchi, with over eight years of focused clinical and academic experience in managing complex cancer cases through Chemotherapy, Targeted Therapy, Immunotherapy, and Multidisciplinary Treatment approaches. After completing his MBBS in 2014, DNB in Medicine in 2018, and DM in Medical Oncology in 2022, Dr. Sharma has built a strong foundation in evidence-based cancer care. He has qualified for the Zonal Round of TYSA in Medical Oncology and cleared the ECMO examination, reinforcing his academic proficiency.
His active participation in global oncology forums, including the American Society of Clinical Oncology (ASCO), highlights his engagement with the latest developments in oncology. Dr. Sharma’s research includes peer-reviewed contributions such as “Impact of Nationwide Lockdown on Cancer Care during COVID-19: A Retrospective Analysis from Western India” (ASCO 2022) and “Tumour-Induced Osteomalacia” (ASEAN Endocrine Journal, 2016). His additional publications, including “Mesenteric Leiomyosarcoma: Long-Term Survival Possible” and “Interstitial Lung Disease in Rheumatoid Arthritis: A Prospective Study at a Tertiary Care Centre” (Indian Journal of Chest Disease & Allied Sciences, 2022), demonstrate his multidisciplinary focus and research depth.
- Zonal Round TYSA, Medical Oncology. Qualified ECMO exam.
- Took part in many national and international conferences (including ASCO).
- Guest Speaker at Jasicon 2022 at Hazaribagh.
- Expert Speaker at Ramgarh IMA CME. Speaker at Deoghar CME on Advances in Colon Cancer.
- Nursing awareness programme at Sarla Birla University (SBU).
- Health awareness program at Kairali School, Ranchi.
- Lung cancer awareness among the masses at Radio Big FM and Radio City.
- Spoke about “Advances in Lung and Breast Cancer” at CME, Daltonganj.
- Impact of Nationwide Lockdown on Cancer Care During COVID-19 Pandemic: "A Retrospective Analysis from Western India" – ASCO, 2022.
- "Tumour Induced Osteomalacia" – published in ASEAN Endocrine Journal, 2016.
- Myocardial Sarcoidosis – "Complete Remission on PET” – sent to NEJM, 2017.
- Mesenteric Leiomyosarcoma – "Long-Term Survival Possible” – sent to Frontiers.
- Interstitial Lung Disease in Rheumatoid Arthritis: "A Prospective Study at a Tertiary Care Centre" – published in The Indian Journal of Chest Diseases & Allied Sciences, 2022.
- Successful Rechallenge of Bevacizumab After Grade 4 Bevacizumab-Induced Hypertension in a Case of Carcinoma Ovary – "Is Rechallenging an Option? A Rare Case Report" – published in GSC Biologicals.
Languages Spoken
Overview
Awards & Achievements
Talks & Publications
- Zonal Round TYSA, Medical Oncology. Qualified ECMO exam.
- Took part in many national and international conferences (including ASCO).
- Guest Speaker at Jasicon 2022 at Hazaribagh.
- Expert Speaker at Ramgarh IMA CME. Speaker at Deoghar CME on Advances in Colon Cancer.
- Nursing awareness programme at Sarla Birla University (SBU).
- Health awareness program at Kairali School, Ranchi.
- Lung cancer awareness among the masses at Radio Big FM and Radio City.
- Spoke about “Advances in Lung and Breast Cancer” at CME, Daltonganj.
- Hindi
- English
- Impact of Nationwide Lockdown on Cancer Care During COVID-19 Pandemic: "A Retrospective Analysis from Western India" – ASCO, 2022.
- "Tumour Induced Osteomalacia" – published in ASEAN Endocrine Journal, 2016.
- Myocardial Sarcoidosis – "Complete Remission on PET” – sent to NEJM, 2017.
- Mesenteric Leiomyosarcoma – "Long-Term Survival Possible” – sent to Frontiers.
- Interstitial Lung Disease in Rheumatoid Arthritis: "A Prospective Study at a Tertiary Care Centre" – published in The Indian Journal of Chest Diseases & Allied Sciences, 2022.
- Successful Rechallenge of Bevacizumab After Grade 4 Bevacizumab-Induced Hypertension in a Case of Carcinoma Ovary – "Is Rechallenging an Option? A Rare Case Report" – published in GSC Biologicals.
Dr. Satish Sharma is a Consultant in the Department of Medical Oncology at Bhagwan Mahavir Manipal Hospitals, Ranchi, with over eight years of focused clinical and academic experience in managing complex cancer cases through Chemotherapy, Targeted Therapy, Immunotherapy, and Multidisciplinary Treatment approaches. After completing his MBBS in 2014, DNB in Medicine in 2018, and DM in Medical Oncology in 2022, Dr. Sharma has built a strong foundation in evidence-based cancer care. He has qualified for the Zonal Round of TYSA in Medical Oncology and cleared the ECMO examination, reinforcing his academic proficiency.
His active participation in global oncology forums, including the American Society of Clinical Oncology (ASCO), highlights his engagement with the latest developments in oncology. Dr. Sharma’s research includes peer-reviewed contributions such as “Impact of Nationwide Lockdown on Cancer Care during COVID-19: A Retrospective Analysis from Western India” (ASCO 2022) and “Tumour-Induced Osteomalacia” (ASEAN Endocrine Journal, 2016). His additional publications, including “Mesenteric Leiomyosarcoma: Long-Term Survival Possible” and “Interstitial Lung Disease in Rheumatoid Arthritis: A Prospective Study at a Tertiary Care Centre” (Indian Journal of Chest Disease & Allied Sciences, 2022), demonstrate his multidisciplinary focus and research depth.
Awards & Achievements
Languages Spoken
Talks & Publications
Overview
- Impact of Nationwide Lockdown on Cancer Care During COVID-19 Pandemic: "A Retrospective Analysis from Western India" – ASCO, 2022.
- "Tumour Induced Osteomalacia" – published in ASEAN Endocrine Journal, 2016.
- Myocardial Sarcoidosis – "Complete Remission on PET” – sent to NEJM, 2017.
- Mesenteric Leiomyosarcoma – "Long-Term Survival Possible” – sent to Frontiers.
- Interstitial Lung Disease in Rheumatoid Arthritis: "A Prospective Study at a Tertiary Care Centre" – published in The Indian Journal of Chest Diseases & Allied Sciences, 2022.
- Successful Rechallenge of Bevacizumab After Grade 4 Bevacizumab-Induced Hypertension in a Case of Carcinoma Ovary – "Is Rechallenging an Option? A Rare Case Report" – published in GSC Biologicals.
Dr. Satish Sharma is a Consultant in the Department of Medical Oncology at Bhagwan Mahavir Manipal Hospitals, Ranchi, with over eight years of focused clinical and academic experience in managing complex cancer cases through Chemotherapy, Targeted Therapy, Immunotherapy, and Multidisciplinary Treatment approaches. After completing his MBBS in 2014, DNB in Medicine in 2018, and DM in Medical Oncology in 2022, Dr. Sharma has built a strong foundation in evidence-based cancer care. He has qualified for the Zonal Round of TYSA in Medical Oncology and cleared the ECMO examination, reinforcing his academic proficiency.
His active participation in global oncology forums, including the American Society of Clinical Oncology (ASCO), highlights his engagement with the latest developments in oncology. Dr. Sharma’s research includes peer-reviewed contributions such as “Impact of Nationwide Lockdown on Cancer Care during COVID-19: A Retrospective Analysis from Western India” (ASCO 2022) and “Tumour-Induced Osteomalacia” (ASEAN Endocrine Journal, 2016). His additional publications, including “Mesenteric Leiomyosarcoma: Long-Term Survival Possible” and “Interstitial Lung Disease in Rheumatoid Arthritis: A Prospective Study at a Tertiary Care Centre” (Indian Journal of Chest Disease & Allied Sciences, 2022), demonstrate his multidisciplinary focus and research depth.
- Hindi
- English
- Zonal Round TYSA, Medical Oncology. Qualified ECMO exam.
- Took part in many national and international conferences (including ASCO).
- Guest Speaker at Jasicon 2022 at Hazaribagh.
- Expert Speaker at Ramgarh IMA CME. Speaker at Deoghar CME on Advances in Colon Cancer.
- Nursing awareness programme at Sarla Birla University (SBU).
- Health awareness program at Kairali School, Ranchi.
- Lung cancer awareness among the masses at Radio Big FM and Radio City.
- Spoke about “Advances in Lung and Breast Cancer” at CME, Daltonganj.
Talks & Publications
Overview
Languages Spoken
Awards & Achievements
Blogs
6 min read FAQ's
Patients often seek Dr. Satish Sharma’s expertise as the Consultant - Medical Oncology at Manipal Hospitals Ranchi. Dr Satish Sharma, Best Medical Oncologist in Ranchi at Manipal Hospitals, brings over 8 years of expertise in chemotherapy, immunotherapy, and multidisciplinary cancer care. Book your appointment today.
To book an appointment with Dr. Satish Sharma at Manipal Hospitals Ranchi, please call 0651 662 1000. Our dedicated team will assist you in scheduling a convenient time for your consultation.
Dr. Satish Sharma has extensive experience and qualifications in Medical Oncology at Manipal Hospitals Ranchi. With expertise spanning MBBS . DNB . Medicine . DM . Medical Oncology, bringing a wealth of knowledge and skill to their practice, ensuring top-notch patient care. Dr. Satish Sharma has also published numerous articles and publications in the field of Medical Oncology.
For your initial appointment with Dr. Satish Sharma, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents. This will help facilitate a comprehensive evaluation and discussion during your appointment.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
